for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson coronavirus vaccine trial to resume soon - Washington Post

Oct 23 (Reuters) - Johnson & Johnson’s coronavirus vaccine trial will resume very soon after investigators concluded a participant’s illness was unrelated to the vaccine, the Washington Post reported on Friday, citing two people familiar with the matter. (Reporting by Munsif Vengattil; Editing by Anil D’Silva)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up